Al-Bari MAA, Ito Y, Ahmed S, Radwan N, Ahmed HS, Eid N (2021) Targeting autophagy with natural products as a potential therapeutic approach for cancer. Int J Mol Sci 22(18):9807. https://doi.org/10.3390/ijms22189807

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baskić D, Popović S, Ristić P, Arsenijević NN (2006) Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridine orange/ethidium bromide. Cell Biol Int 30(11):924–932

Article  PubMed  Google Scholar 

Bowers, KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis J, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK, Shan Y, Shaw D (2006) In: Proceedings of the ACM/IEEE conference on supercomputing (SC06), November 11–17

Cova D, De Angelis L, Monti E (1992) Piccinini F (1992) Subcellular distribution of two spin trapping agents in rat heart: possible explanation for their different protective effects against doxorubicin-induced cardiotoxicity. Free Rad Res Commun 15:353–360

Article  CAS  Google Scholar 

Cunha-Oliveira T, Ferreira LL, Coelho AR, Deus CM, Oliveira PJ (2018) Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol 348:1–13

Article  CAS  PubMed  Google Scholar 

Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717

Article  PubMed  PubMed Central  Google Scholar 

Davies KJ, Doroshow JH (1986) Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 261:3060–3067

Article  CAS  PubMed  Google Scholar 

Ding M, Shi R, Cheng S, Li M, De D, Liu C, Gu X, Li J, Zhang S, Jia M, Fan R, Pei J, Fu F (2022) Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch. Redox Biol 52:102311

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doroshow JH, Davies KJ (1986) Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J Biol Chem 261:3068–3074

Article  CAS  PubMed  Google Scholar 

Drwal MN, Banerjee P, Dunkel M, Wettig MR, Preissner R (2014) ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res 42(W1):W53-58

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Agamy DS, El-Harbi KM, Khoshhal S, Ahmed N, Elkablawy MA, Shaaban AA, Abo-Haded HM (2018) Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways. Cancer Manag Res 11:47–61

Article  PubMed  PubMed Central  Google Scholar 

Han X, Pan J, Ren D, Cheng Y, Fan P, Lou H (2008) Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. Food Chem Toxicol 46(9):3140–3146

Article  CAS  PubMed  Google Scholar 

Harder E, Damm W, Maple J, Wu C, Reboul M, Xiang JY, Wang L, Lupyan D, Dahlgren MK, Knight JL, Kaus JW, Cerutti DS, Krilov G, Jorgensen WL, Abel R, Friesner RA (2016) OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comp 12(1):281–296

Article  CAS  Google Scholar 

Karin M (1999) How NF-кß is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18(49):6867–6874

Article  CAS  PubMed  Google Scholar 

Kelleni MT, Amin EF, Abdelrahman AM (2015) Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in rats: impact of oxidative stress, inflammation, and apoptosis. J Toxicol. https://doi.org/10.1155/2015/424813

Article  PubMed  PubMed Central  Google Scholar 

Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127(6):1109–1122

Article  CAS  PubMed  Google Scholar 

Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, Barsh GS, Clayton DA (1998) Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nature Gen 18(3):231–236

Article  CAS  Google Scholar 

Laskar YB, Mazumder PB, Talukdar AD (2023) Hibiscus sabdariffa anthocyanins are potential modulators of estrogen receptor alpha activity with favourable toxicology: a computational analysis using molecular docking, ADME/Tox prediction, 2D/3D QSAR and molecular dynamics simulation. J Biomol Struct Dyn 41(2):611–633

Article  CAS  PubMed  Google Scholar 

Linders AN, Dias IB, López Fernández T, Tocchetti CG, Bomer N, Van der Meer P (2024) A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. NPJ Aging 10(1):9

Article  PubMed  PubMed Central  Google Scholar 

Liu D, Ma Z, Di S, Yang Y, Yang J, Xu L, Reiter RJ, Qiao S, Yuan J (2018) AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Free Rad Biol Med 129:59–72

Article  CAS  PubMed  Google Scholar 

Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56(2):185–229

Article  CAS  PubMed  Google Scholar 

Neog MK, Joshua Pragasam S, Krishnan M, Rasool M (2017) p-Coumaric acid, a dietary polyphenol ameliorates inflammation and curtails cartilage and bone erosion in the rheumatoid arthritis rat model. BioFactors (Oxford, England) 43(5):698–717

Article  CAS  PubMed  Google Scholar 

Nordgren KKS, Wallace KB (2020) Disruption of the Keap1/Nrf2-Antioxidant response system after chronic doxorubicin exposure in vivo. Cardiovasc Toxicol 20(6):557–570

Article  CAS  PubMed  Google Scholar 

Pei K, Ou J, Huang J, Ou S (2016) p-Coumaric acid and its conjugates: dietary sources, pharmacokinetic properties and biological activities. J Sci Food Agri 96(9):2952–2962

Article  CAS  Google Scholar 

Ponnian SMP, Stanely SP, Roy AJ (2024) Cardioprotective effects of p-coumaric acid on tachycardia, inflammation, ion pump dysfunction, and electrolyte imbalance in isoproterenol-induced experimental myocardial infarction. J Biochem Mol Toxicol 38(3):e23668

Article  CAS  PubMed  Google Scholar 

Rimando AM, Nagmani R, Feller DR, Yokoyama W (2005) Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agri Food Chem 53(9):3403–3407

Article  CAS  Google Scholar 

Rodríguez-Roque MJ, de Ancos B, Sánchez-Moreno C, Cano MP, Elez-Martínez P (2021) Phenolic compounds in food: characterization and health benefits. J Food Comp Anal 97:103773

Google Scholar 

Rowe GC, Jiang A, Arany Z (2010) PGC-1 coactivators in cardiac development and disease. Circ Res 107(7):825–838

Article  CAS  PubMed  PubMed Central  Google Scholar 

Studneva I, Palkeeva M, Veselova O, Molokoedov A, Ovchinnikov M, Sidorova M, Pisarenko O (2019) Protective effects of a novel agonist of galanin receptors against doxorubicin-induced cardiotoxicity in rats. Cardiovasc Toxicol 19:136–146

Article  CAS  PubMed  Google Scholar 

Sunitha MC, Dhanyakrishnan R, PrakashKumar B, Nevin KG (2018) p-Coumaric acid-mediated protection of H9c2 cells from Doxorubicin-induced cardiotoxicity: Involvement of augmented Nrf2 and autophagy. Biomed Pharmacother 102:823–832

Article  CAS  PubMed  Google Scholar 

Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157–170

Article  CAS  PubMed  Google Scholar 

Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, Okabe K, Ishikita A, Matsushima S, Koumura T, Yamada KI, Imai H, Tsutsui H (2020) Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight 5(9):e132747